The Bone Marrow Transplantation Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia; The Royal Brisbane and Women's Hospital, Herston, Queensland 4029, Australia; and
The Bone Marrow Transplantation Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia;
J Immunol. 2014 Jun 1;192(11):5426-33. doi: 10.4049/jimmunol.1302490. Epub 2014 Apr 30.
The stimulation of naive donor T cells by recipient alloantigen is central to the pathogenesis of graft-versus-host disease after bone marrow transplantation (BMT). Using mouse models of transplantation, we have observed that donor cells become "cross-dressed" in very high levels of recipient hematopoietic cell-derived MHC class I and II molecules following BMT. Recipient-type MHC is transiently present on donor dendritic cells (DCs) after BMT in the setting of myeloablative conditioning but is persistent after nonmyeloablative conditioning, in which recipient hematopoietic cells remain in high numbers. Despite the high level of recipient-derived alloantigen present on the surface of donor DCs, donor T cell proliferative responses are generated only in response to processed recipient alloantigen presented via the indirect pathway and not in response to cross-dressed MHC. Assays in which exogenous peptide is added to cross-dressed MHC in the presence of naive TCR transgenic T cells specific to the MHC class II-peptide combination confirm that cross-dressed APC cannot induce T cell proliferation in isolation. Despite failure to induce T cell proliferation, cross-dressing by donor DCs contributes to generation of the immunological synapse between DCs and CD4 T cells, and this is required for maximal responses induced by classical indirectly presented alloantigen. We conclude that the process of cross-dressing by donor DCs serves as an efficient alternative pathway for the acquisition of recipient alloantigen and that once acquired, this cross-dressed MHC can assist in immune synapse formation prior to the induction of full T cell proliferative responses by concurrent indirect Ag presentation.
供者 T 细胞被受者同种异体抗原刺激是骨髓移植(BMT)后移植物抗宿主病发病机制的核心。通过移植小鼠模型,我们观察到供者细胞在 BMT 后高水平地被受者造血细胞衍生的 MHC Ⅰ和Ⅱ类分子“交叉呈递”。在清髓性条件下,BMT 后供者树突状细胞(DC)短暂存在受者 MHC,但在非清髓性条件下持续存在,此时受者造血细胞仍大量存在。尽管供者 DC 表面存在高水平的受者来源同种异体抗原,但供者 T 细胞增殖反应仅在通过间接途径呈递加工的受者同种异体抗原时产生,而不是在对交叉呈递 MHC 时产生。在针对 MHC Ⅱ-肽复合物的幼稚 TCR 转基因 T 细胞存在的情况下,在外源肽添加到交叉呈递 MHC 中的测定中证实,交叉呈递 APC 不能单独诱导 T 细胞增殖。尽管不能诱导 T 细胞增殖,但供者 DC 的交叉呈递有助于 DC 和 CD4 T 细胞之间免疫突触的形成,这对于通过经典间接呈递的同种异体抗原诱导最大反应是必需的。我们得出结论,供者 DC 的交叉呈递过程是获得受者同种异体抗原的有效替代途径,一旦获得,这种交叉呈递的 MHC 可有助于在诱导完全 T 细胞增殖反应之前形成免疫突触。